CVRx Inc (CVRX)
14.13
-0.07
(-0.49%)
USD |
NASDAQ |
Nov 14, 16:00
14.10
-0.03
(-0.21%)
After-Hours: 20:00
CVRx Research and Development Expense (Quarterly): 2.504M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.504M |
| June 30, 2024 | 2.765M |
| March 31, 2024 | 3.057M |
| December 31, 2023 | 2.241M |
| September 30, 2023 | 2.696M |
| June 30, 2023 | 3.28M |
| March 31, 2023 | 3.416M |
| December 31, 2022 | 3.046M |
| September 30, 2022 | 2.293M |
| June 30, 2022 | 2.355M |
| Date | Value |
|---|---|
| March 31, 2022 | 2.258M |
| December 31, 2021 | 1.797M |
| September 30, 2021 | 1.699M |
| June 30, 2021 | 2.255M |
| March 31, 2021 | 1.75M |
| December 31, 2020 | 0.51M |
| September 30, 2020 | 1.50M |
| June 30, 2020 | 2.131M |
| March 31, 2020 | 2.269M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.51M
Minimum
Dec 2020
3.416M
Maximum
Mar 2023
2.306M
Average
2.269M
Median
Mar 2020
Research and Development Expense (Quarterly) Benchmarks
| NeuroOne Medical Technologies Corp | 1.195M |
| SINTX Technologies Inc | 1.677M |
| Nutriband Inc | 0.774M |
| enVVeno Medical Corp | 2.859M |
| Beyond Air Inc | 6.009M |